The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF

NCT05089539 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: Angiotensin Receptor-Neprilysin Inhibition
DRUG: Placebo

Sponsor

Chongqing Medical University